Belite Bio

BLTE

BLTE Belite Bio NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    BLTE Chart
    See on advanced chart >

    About

    Belite Bio, Inc was incorporated in the Cayman Islands on March 27, 2018. The company is a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration with...
    • Highlight
      A biopharmaceutical company developing new treatments for currently incurable eye diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      04/29/2022
    • Established Date
      03/27/2018
    • Full-time Employees
      16
    • Address
      12750 High Bluff Drive Suite 475 San Diego CA 92130
    • Tel
      1-858-2466240
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)
    cache time: 2024-02-22 08:20:00